Skip to main content

Find Clinical Trials

Home
Conditions
Diabetes Mellitus, Type 2

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

7,980 public trials 715 recruiting studies

Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

Leptin and Visfatin in Diabetic Patients With Periodontitis Before and After Periodontal Therapy

NCT02174146

Conditions: Chronic Disease, Chronic Periodontitis, Diabetes Mellitus, +13 more
Locations: Faculty of oral and dental medicine Cairo, Egypt

View Trial Details

Completed

Brown Adipose Tissue and Body Mass Index

NCT02173834

Conditions: Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +11 more
Locations: Academic Medical Center Amsterdam, Netherlands

View Trial Details

Completed

Observational Study to Evaluate the Safety and Efficacy of NovoMix® 70 in Type 2 Diabetes

NCT00704223

Conditions: Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations: Vienna, Austria

View Trial Details

Completed

Anesthesia With Epinephrine in Diabetes Patients is Safe and Effective

NCT02173067

Conditions: Cardiovascular Diseases, Coronary Disease, Diabetes Mellitus, +9 more
Locations: Unit of Dentistry, Heart Institute São Paulo, Brazil

View Trial Details

Completed

An Observational Study of Insulin Aspart and, if Necessary, Insulin Levemir (FlexPen®) in the Evening or at Bedtime

NCT01487421

Conditions: Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations: Mainz, Germany

View Trial Details

Completed

A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Indonesia

NCT00788853

Conditions: Autoimmune Diseases, Diabetes, Diabetes Complications, +8 more
Locations: Jakarta, Indonesia

View Trial Details

Completed

12 Weeks Treatment With 3 Different Doses of BI 10773 in Type 2 Diabetic Patients

NCT00789035

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations: 1245.9.54001 Boehringer Ingelheim Investigational Site Capital Federal, Argentina

1245.9.54002 Boehringer Ingelheim Investigational Site Capital Federal, Argentina

1245.9.54007 Boehringer Ingelheim Investigational Site Capital Federal, Argentina

1245.9.54008 Boehringer Ingelheim Investigational Site Capital Federal, Argentina

View all 74 locations

View Trial Details

Completed

Saxagliptin and Atherosclerosis

NCT01552018

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +12 more
Locations: Center for Clinical Heart Research, Dept. of Cardiology, Oslo University Hospital Ullevaal Oslo, Norway

View Trial Details

Completed

Empagliflozin (BI 10773) Dose Finder Study in Japanese Patients With Type 2 Diabetes Mellitus

NCT01193218

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations: 1245.38.016 Boehringer Ingelheim Investigational Site Chiyoda-ku, Tokyo, Japan

1245.38.001 Boehringer Ingelheim Investigational Site Chuo-ku, Tokyo, Japan

1245.38.003 Boehringer Ingelheim Investigational Site Chuo-ku, Tokyo, Japan

1245.38.002 Boehringer Ingelheim Investigational Site Hachioji, Tokyo, Japan

View all 32 locations

View Trial Details

Completed

Safety and Efficacy of BI 10773 as add-on to Insulin Regimen in Patients With Type 2 Diabetes Mellitus

NCT01306214

Conditions: Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +10 more
Locations: 1245.49.10005 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States

1245.49.10011 Boehringer Ingelheim Investigational Site Chandler, Arizona, United States

1245.49.10004 Boehringer Ingelheim Investigational Site Tucson, Arizona, United States

1245.49.10002 Boehringer Ingelheim Investigational Site Corona, California, United States

View all 103 locations

View Trial Details